Welcome to the TSP Talk Forums forums.

You are currently viewing our boards as a guest which gives you limited access to view most discussions and access our other features. By joining our free community you will have access to post topics, communicate privately with other members (PM), respond to polls, upload content, join our AutoTracker, and access many other special features. Registration is simple and absolutely free so please, join our community today!

If you have any problems with the registration process or your account login, please contact us.
The Forum works well on MOBILE devices without an app: Just go to: https://forum.tsptalk.com
Please read our AutoTracker policy on the IFT deadline and remaining active. Thanks!
$ - Premium Service Content (Info) | AutoTracker Monthly Winners | Is Gmail et al, Blocking Our emails?

Find us on: Facebook & X | Posting Copyrighted Material
Join the TSP Talk AutoTracker: How to Get Started | Login | Main AutoTracker Page
TSP Talk's NFL Survivor Pool
October Monthly AutoTracker Winners

'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces ma

Thread starter NewsFeeder
Start date Oct 14, 2023

NewsFeeder

Headline News

Oct 14, 2023

'Miracle drug' euphoria: Experts warn widespread use of weight loss medicine faces major hurdles

Two experts see major challenges facing the adoption of Novo Nordisk and Eli Lilly's obesity drugs.

More @ CNBC...

You must log in or register to reply here.

Similar threads

This new weight loss drug ETF bets big on two of the industry's leading players

Replies: 0

Views: 178

May 27, 2024

NewsFeeder

Facebook X (Twitter) LinkedIn Reddit Pinterest Tumblr WhatsApp Email Link

This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.

Accept Learn more…

Back

Top